期刊文献+

上海市青浦区2012年疑似预防接种异常反应监测分析

Surveillance on suspected adverse events following immunization in Qingpu district of Shanghai city in 2012
原文传递
导出
摘要 目的分析青浦区2012年疑似预防接种异常反应(AEFI)的发生情况,评价AEFI监测系统运行状况及预防接种安全性。方法采用描述性流行病学方法对2012年青浦区AEFI监测资料进行分析。结果青浦区2012年共报告AEFI586例,报告发生率为136.56例/10万剂,其中一般反应581例(99.15%),异常反应4例(0.68%),偶合征1例(0.17%);较多分布在5~8月(49.66%);主要为发热(50.34)和局部红肿(33.96%);报告发生数较多的产品有白百破、流脑A群、流感菌(HIB);报告发生率居前3位的产品是:五联、白百破、流脑A群。586例AEFI中,治愈584例,好转2例。结论青浦区AEF!监测敏感性较高,但仍需要加强AEFI监测工作,应进一步强化预防接种规范操作,注重公众沟通。 Objective To analyze the occurrence of suspected adverse events following immunization (AEFI) in Qingpu district, and to evaluate the operation of AEFI surveillance system and the safety of vaccination. Methods Descriptive epidemiology was adopted to analyze AEFI data in Qingpu district in 2012. Results A total of 586 AEFI cases were re- ported, with an incidence of 136.56/103, including 581 eases with common reactions(99.15% ), 4 cases with abnormal reactions(0.68% ), 1 case with coincidental events (0.17%). AEFI cases tended to occur from May to August (49. 66% ) , mainly including fever ( 50.34% ) and local swelling ( 33.96% ). AEFI cases were likely to occur after the injec- tion of DPT vaccine, MenV - A vaccine and hemophilus influenza type B (HIB) vaccine, and the top three were Pcnta - components vaccine, DPT vaccine, MenV - A vaccine. Of the 586 reported cases, 594 were cured, 2 improved. Conclu- sions AEFI surveillance shows a higher sensitivity in Qingpu district, but needs further improving. Standardized vaccina- tion should be strengthened, as wall as public communication.
出处 《社区医学杂志》 2013年第24期25-28,共4页 Journal Of Community Medicine
关键词 预防接种 疑似预防接种异常反应 青浦区 vaccination suspected adverse events following immunization Qingpu district
  • 相关文献

参考文献7

二级参考文献26

  • 1刘东磊,苗良,孙美平.北京市2002年预防接种后不良反应分析[J].中国计划免疫,2004,10(5):261-263. 被引量:30
  • 2张苏琳,王越,孙骏,徐厚明.中美预防接种不良事件监测系统比较[J].药物流行病学杂志,2005,14(5):309-313. 被引量:16
  • 3国家统计局.2009年中国统计年鉴[M].北京:中国统计出版社,2009.
  • 4[2]Lawrence GL,Aratchige PE,Boyd I,etal.Annual report on surveillance of adverse events following immunization in Australia,2006[J].Commun Dis Intell,2007,31(3):269-282.
  • 5[4]Clements cJ.关于疫苗安全的补充信息[R].世界卫生组织疫苗和生物制品司,2000.
  • 6[5]Michael D,Kathryn M,Roberta B,et al.Comparative trial in infants of fourconjugate Haemophlius influenzae type by accines[J].The journal of Pediatrics,1992,120(2):184-189.
  • 7[6]Usonis V,Bakasenas V.Does concomitant injection of a combined diphtheria-tetanus-acellular pertusis-hepatitis B virus-inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influanzae type b conjugate vaccines?[J].Eur J Pediatr,1999,158:398-402.
  • 8卫生部.全国疑似预防接种异常反应监测方案(试行).2008[S].
  • 9Weigong Zhou, Vitali Pool, John K, et al. Surveillance for Safety After Immunization:Vaccine Adverse Event Reporting System (VAERS)- United States, 1991-2001 [J]. MMWR, 2003, 52 (No.SS-1): 1-24.
  • 10卫生部.《2009年秋冬季甲型H1N1流感疫苗预防接种指导意见》[S].2009.

共引文献265

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部